Yamamoto-Furusho, J. K. Et Al. 2020. Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study. DIGESTIVE AND LIVER DISEASE , vol.52, no.8 , 869-877.

Yamamoto-Furusho, J. K., Al Harbi, O., Armuzzi, A., Chan, W., de Leon, E. P., Qian, J., ... Shapina, M.(2020). Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study. DIGESTIVE AND LIVER DISEASE , vol.52, no.8, 869-877.

Yamamoto-Furusho, Jesus Et Al. "Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study," DIGESTIVE AND LIVER DISEASE , vol.52, no.8, 869-877, 2020

Yamamoto-Furusho, Jesus K. Et Al. "Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study." DIGESTIVE AND LIVER DISEASE , vol.52, no.8, pp.869-877, 2020

Yamamoto-Furusho, J. K. Et Al. (2020) . "Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study." DIGESTIVE AND LIVER DISEASE , vol.52, no.8, pp.869-877.

@article{article, author={Jesus K. Yamamoto-Furusho Et Al. }, title={Incidence of suboptimal response to tumor necrosis factor antagonist therapy in inflammatory bowel disease in newly industrialised countries: The EXPLORE study}, journal={DIGESTIVE AND LIVER DISEASE}, year=2020, pages={869-877} }